Prot #VS-0145-225: A Muti-Center, Phase 2, Open Label, Parallel Cohort Study of Efficacy and Safety of Duvelisib in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/6/18 → 8/6/24

Funding

  • Parexel ((OE) Prot #VS-0145-225 // (OE) Prot #VS-0145-225)
  • Verastem, Inc. ((OE) Prot #VS-0145-225 // (OE) Prot #VS-0145-225)